Literature DB >> 24609062

Tocilizumab-induced leucocytoclastic vasculitis in a patient with rheumatoid arthritis.

Saori Sakaue1, Shuji Sumitomo2, Kanae Kubo1, Keishi Fujio1, Kazuhiko Yamamoto1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24609062     DOI： 10.1093/rheumatology/keu008

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  9 in total

Review 1.  Rheumatoid Vasculitis: A Diminishing Yet Devastating Menace.

Authors:  Shweta Kishore; Lisa Maher; Vikas Majithia
Journal:  Curr Rheumatol Rep       Date:  2017-07       Impact factor: 4.592

Review 2.  Tocilizumab-induced anaphylaxis in patients with adult-onset Still's disease and systemic juvenile idiopathic arthritis: a case-based review.

Authors:  Eun Hye Park; Eun Young Lee; Kichul Shin; Hyoun-Ah Kim
Journal:  Rheumatol Int       Date:  2019-10-09       Impact factor: 2.631

Review 3.  Connective Tissue Disorder-Associated Vasculitis.

Authors:  Aman Sharma; Aadhaar Dhooria; Ashish Aggarwal; Manish Rathi; Vinod Chandran
Journal:  Curr Rheumatol Rep       Date:  2016-06       Impact factor: 4.592

Review 4.  Diagnosis and management of leukocytoclastic vasculitis.

Authors:  Paolo Fraticelli; Devis Benfaremo; Armando Gabrielli
Journal:  Intern Emerg Med       Date:  2021-03-13       Impact factor: 3.397

5.  Accelerated subcutaneous nodulosis in patients with rheumatoid arthritis treated with tocilizumab: a case series.

Authors:  Rossella Talotta; Fabiola Atzeni; Alberto Batticciotto; Maria Chiara Ditto; Maria Chiara Gerardi; Piercarlo Sarzi-Puttini
Journal:  J Med Case Rep       Date:  2018-06-03

6.  Tocilizumab-induced granulomatous vasculitis and cutaneous actinomycosis in a patient with rheumatoid arthritis.

Authors:  Justyna Ziandarska; Magdalena Górecka-Sokołowska; Rafał Czajkowski
Journal:  Postepy Dermatol Alergol       Date:  2022-09-01       Impact factor: 1.664

Review 7.  Vasculitis induced by biological agents used in rheumatology practice: A systematic review.

Authors:  Camila da Silva Cendon Duran; Adriane Souza da Paz; Mittermayer Barreto Santiago
Journal:  Arch Rheumatol       Date:  2021-12-24       Impact factor: 1.007

Review 8.  Immune-related adverse events of biological immunotherapies used in COVID-19.

Authors:  Daniela Baracaldo-Santamaría; Giovanna María Barros-Arias; Felipe Hernández-Guerrero; Alejandra De-La-Torre; Carlos-Alberto Calderon-Ospina
Journal:  Front Pharmacol       Date:  2022-08-25       Impact factor: 5.988

Review 9.  Drug-Induced Vasculitis: New Insights and a Changing Lineup of Suspects.

Authors:  Rafael G Grau
Journal:  Curr Rheumatol Rep       Date:  2015-12       Impact factor: 4.686
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.